Milo Taylor, a postbaccalaureate fellow at the NIH, is studying how immune cells recognize and fight infections. Her research ...

Immunologists at UNIGE have revealed a previously unknown anti-tumor role of CD4 T lymphocytes, marking a breakthrough that ...

By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site ...

In the fight against cancer, immunotherapy—which aims to boost the body's natural defenses against cancer—is experiencing ...

Whether antiretroviral therapy (ART) is always completely suppressive, or HIV might continue to replicate at low levels despite ART in some people with HIV (PWH), is still debated. Here, we ...

A saliva test may ultimately serve as a potential marker of therapeutic response to IFN beta-1a in multiple sclerosis patients.

Cite this: Saliva Soluble HLA as a Potential Marker of Response to Interferon-β1a in Multiple Sclerosis: A Preliminary Study - Medscape - Jul 01, 2007.

(12/20) complete response rate after treatment with EO2463 in combination with lenalidomide and rituximab (R2) <li /> EO ...

Graft vs. host disease (GVHD) is a serious condition that can occur after a stem cell transplant from a donor, where the transplanted cells attack your body.

HLA markers help match donors and recipients more effectively, reducing the risk of organ rejection and improving transplant outcomes.

The results showed that the association between Hla-C01 and Hla-B44 with the risk of severe Covid-19 varied and eventually disappeared after the first pandemic wave.

In Tardive Dyskinesia, are Risk and Severity Predictable with HLA Markers? —The exact pathology of tardive dyskinesia is still unclear, but the potential genetic factors these investigators have ...